Giovanni Ughi to Immunosuppressive Agents
This is a "connection" page, showing publications Giovanni Ughi has written about Immunosuppressive Agents.
Connection Strength
0.234
-
Dubois C, Bennett J, Dens J, De Cock D, Desmet W, Belmans A, Ughi GJ, Sinnaeve P, Vrolix M, D'hooge J, Adriaenssens T. COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial. EuroIntervention. 2016 Apr 20; 11(13):1457-67.
Score: 0.107
-
Adriaenssens T, Ughi GJ, Dubois C, De Cock D, Onsea K, Bennett J, Wiyono S, Sinnaeve P, Coosemans M, Ferdinande B, Belmans A, D'hooge J, Desmet W. STACCATO (Assessment of Stent sTrut Apposition and Coverage in Coronary ArTeries with Optical coherence tomography in patients with STEMI, NSTEMI and stable/unstable angina undergoing everolimus vs. biolimus A9-eluting stent implantation): a randomised controlled trial. EuroIntervention. 2016 Apr 08; 11(14):e1619-26.
Score: 0.107
-
Dubois C, Adriaenssens T, Ughi G, Wiyono S, Bennett J, Coosemans M, Ferdinande B, Sinnaeve P, D'hooge J, Desmet W. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent? in combination with XIENCE-V? stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent? with an additional XIENCE-v? everolimus-eluting stent in coronary bifurcation lesions) study. Catheter Cardiovasc Interv. 2013 Feb; 81(3):E155-64.
Score: 0.021